WHO ICTRP trial
Randomized, open label, comparative parallel group study to assess efficacy and…
EUCTR2004-005187-24-IT · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2004-005187-24-IT |
|---|---|
| Public title | Randomized, open label, comparative parallel group study to assess efficacy and safety of flexible dosages of OROS hydromorphone once-daily compared to sustained release oxycodone twice-daily in subjects with chronic non-malignant pain severe enough to require continuous opioid therapy. |
| Scientific title | Randomized, open label, comparative parallel group study to assess efficacy and safety of flexible dosages of OROS hydromorphone once-daily compared to sustained release oxycodone twice-daily in subjects with chronic non-malignant pain severe enough to require continuous opioid therapy. |
| Primary sponsor | JANSSEN-CILAG |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Czech Republic;Germany;Italy |
| Conditions | Treatment of chronic non-malignant pain MedDRA version: 6.1 Level: PT Classification code 10033371 |
| Interventions | Product Name: OROS hydromorphone Product Code: 71-68-1 Pharmaceutical Form: Prolonged-release tablet INN or Proposed INN: Hydromorphone Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 8- Product Name… |
| Registration date | Aug 24, 2005 |
| Secondary IDs | OROS-ANA-3001 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: